Neumora Therapeutics Inc (NASDAQ: NMRA) on Tuesday, plunged -3.31% from the previous trading day, before settling in for the closing price of $1.81. Within the past 52 weeks, NMRA’s price has moved between $0.61 and $11.57.
A company in the Healthcare sector has dropped its sales by -586.93% annually for the last half of the decade. The company achieved an average annual earnings per share of 6.64%. With a float of $57.94 million, this company’s outstanding shares have now reached $161.95 million.
In an organization with 110 employees, it is important to assess its efficiency.
Neumora Therapeutics Inc (NMRA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Neumora Therapeutics Inc is 65.32%, while institutional ownership is 18.66%. The most recent insider transaction that took place on Nov 11 ’25, was worth 307,026. In this transaction an insider of this company sold 114,703 shares at a rate of $2.68, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 11 ’25, when Company’s Director proposed sale 114,703 for $2.68, making the entire transaction worth $307,027.
Neumora Therapeutics Inc (NMRA) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.37 earnings per share (EPS) for the period topping the consensus outlook (set at -0.44) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.90% during the next five years compared to -586.93% drop over the previous five years of trading.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Neumora Therapeutics Inc (NMRA) is currently performing well based on its current performance indicators. A quick ratio of 6.85 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -1.02 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
Let’s dig in a bit further. During the last 5-days, its volume was 1.14 million. That was inferior than the volume of 1.8 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.75%.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 19.35%, which indicates a significant increase from 10.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1217 in the past 14 days, which was lower than the 0.1634 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2884, while its 200-day Moving Average is $1.4977. However, in the short run, Neumora Therapeutics Inc’s stock first resistance to watch stands at $1.8870. Second resistance stands at $2.0240. The third major resistance level sits at $2.1225. If the price goes on to break the first support level at $1.6515, it is likely to go to the next support level at $1.5530. The third support level lies at $1.4160 if the price breaches the second support level.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
Market capitalization of the company is 292.40 million based on 167,089K outstanding shares. Right now, sales total 0 K and income totals -243,790 K. The company made 0 K in profit during its latest quarter, and -56,760 K in sales during its previous quarter.
